RXFP2 agonist 2
RXFP2 agonist 2 is a selective, orally active and allosteric RXFP2 agonist with an EC50 value of 0.38 μM. RXFP2 agonist 2 induces osteoblast mineralization. RXFP2 agonist 2 increases bone formation in female mice. RXFP2 agonist 2 has the potential for the research of osteoporosis[1].
Product Specifications
CAS Number
2971704-85-3
UNSPSC
12352005
Target
RXFP Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/rxfp2-agonist-2.html
Solubility
10 mM in DMSO
Smiles
O=C(N1[C@H]2CN(CC1)C(COC3=CC=C(C=C3I)OC(F)(F)F)=O)C4=CC(C5=CC(C(F)(F)F)=CC(C(F)(F)F)=C5)=CC=C4NC2=O
Molecular Formula
C29H19F9IN3O5
Molecular Weight
787.37
References & Citations
[1]Esteban-Lopez M, et al. Discovery of small molecule agonists of the Relaxin Family Peptide Receptor 2. Commun Biol. 2022 Nov 4;5 (1) :1183.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Anti-GOLGA7 Antibody Fluoro488 Conjugated
MRNA (mRNA-capping Enzyme, HCAP1, HCE, RNGTT, CAP1A) (MaxLight 750) discontinued
